Background/Purpose: Daily adjuvant endocrine therapy (AET) is prescribed to women for 5–10 years for hormone-sensitive breast cancer (60%–75% of breast cancer cases) to prevent recurrence and reduce mortality. However, a significant number of women experience AET-related issues that may affect quality of life and AET adherence. Few interventions to enhance AET adherence have been developed and tested, and the few studies available to date have generally produced inconclusive results. A telephone consultation program about AET using motivational interviewing (MI) principles was developed to be delivered by nurse navigators. This study aimed to describe women's experiences and perceived impact of this supportive program. Methods: 20 women ...
PURPOSE: Oral anti-cancer medications are increasingly common and endocrine therapies represent the ...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer s...
Background: Breast cancer is the most common cancer in women worldwide. Approximately 80% of breast ...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast ...
Introduction Patient adherence to adjuvant endocrine therapy (AET) after a diagnosis of hormone-sens...
BackgroundOral anti-cancer treatments such as adjuvant endocrine therapies (AET) for breast cancer s...
Stephanie B Wheeler,1,2 Megan C Roberts,1 Diane Bloom,1 Katherine E Reeder-Hayes,2,3 Maya Espada,1 J...
Thesis (Ph.D.)--University of Washington, 2015Estrogen receptor-positive (ER+) breast cancer is diag...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this s...
Background: Oral endocrine therapy (ET) is an inexpensive and effective therapy for hormone receptor...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
PURPOSE: Oral anti-cancer medications are increasingly common and endocrine therapies represent the ...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer s...
Background: Breast cancer is the most common cancer in women worldwide. Approximately 80% of breast ...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast ...
Introduction Patient adherence to adjuvant endocrine therapy (AET) after a diagnosis of hormone-sens...
BackgroundOral anti-cancer treatments such as adjuvant endocrine therapies (AET) for breast cancer s...
Stephanie B Wheeler,1,2 Megan C Roberts,1 Diane Bloom,1 Katherine E Reeder-Hayes,2,3 Maya Espada,1 J...
Thesis (Ph.D.)--University of Washington, 2015Estrogen receptor-positive (ER+) breast cancer is diag...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Adherence to adjuvant endocrine therapy (AET) for breast cancer is suboptimal. The purpose of this s...
Background: Oral endocrine therapy (ET) is an inexpensive and effective therapy for hormone receptor...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
PURPOSE: Oral anti-cancer medications are increasingly common and endocrine therapies represent the ...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
Adjuvant endocrine therapy (AET) has substantially improved the mortality rate among breast cancer s...